EGFR-IN-34
Product Specifications
Target
Others|||EGFR
Related Pathways
Tyrosine Kinase/Adaptors|||Angiogenesis|||Others|||JAK/STAT signaling
Bioactivity
EGFR-IN-34 is a low-toxicity, acrylamide derivative antitumor agent that is a potent inhibitor of EGFR. Among others, overexpression and mutation of the epidermal growth factor receptor (EGFR) has been shown to lead to uncontrolled cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-34 exhibits potential for research in EGFR mutation-related diseases.
Smiles
NC1=C(C(C2=CC=C(OCC3=NC=CC=C3)C(Cl)=C2)=CN4[C@H]5CN(C(C=C)=O)CCC5)C4NC=N1
Molecular Formula
C26H27ClN6O2
Molecular Weight
490.98
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/848CA7DD-D2D6-401C-94A5-44629966EE55/T63300
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1371122-01 0.02 mg (E-Coli)
Recombinant Clostridium perfringens Triosephosphate isomerase (tpiA)
Ask
View Details MBS1371122-02 0.1 mg (E-Coli)
Recombinant Clostridium perfringens Triosephosphate isomerase (tpiA)
Ask
View Details 
MBS1371122-03 0.02 mg (Yeast)
Recombinant Clostridium perfringens Triosephosphate isomerase (tpiA)
Ask
View Details MBS1371122-04 0.1 mg (Yeast)
Recombinant Clostridium perfringens Triosephosphate isomerase (tpiA)
Ask
View Details 
MBS1371122-05 0.02 mg (Baculovirus)
Recombinant Clostridium perfringens Triosephosphate isomerase (tpiA)
Ask
View Details MBS1371122-06 0.02 mg (Mammalian-Cell)
Recombinant Clostridium perfringens Triosephosphate isomerase (tpiA)
Ask
View Details